Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Sebastiano Buti

78PUBLICATIONS
278CO-AUTHORS
Predictive and prognostic markersSurface water quality processes and contaminated sediment assessmentCancer therapy (excl. chemotherapy and radiation therapy)Nutrigenomics and personalised nutritionMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (78)

Sort by Publication Date:
|Jul 15, 2026
PSMA PET in Lymph Node Staging of Prostate Cancer: From Diagnostic Accuracy to Clinical Decision-Making.

|May 27, 2026
Microplastics as both a driver of genitourinary cancers and a deliverer of treatments.

|Jan 28, 2026
Fecal microbiota transplantation plus pembrolizumab and axitinib in metastatic renal cell carcinoma: the randomized phase 2 TACITO trial.

Serena Porcari, Chiara Ciccarese, Vitor Heidrich

|Jan 06, 2026
Dissecting the impact of Controlling Nutritional Status (CONUT) score on survival outcomes and immune-inflammatory profiles in patients with advanced NSCLC undergoing first-line immunotherapy.

Federica Pecci, Giulia Mazzaschi, Alessandra Dodi

|Dec 16, 2025
Reply to: Comments on "Toxicity-related immunotherapy discontinuation and outcome in patients with advanced renal cell carcinoma treated with immune-based combinations (ARON-1 study)".

Javier Molina-Cerrillo, Giandomenico Roviello, Ondrej Fiala

|Nov 04, 2025
Toxicity-related immunotherapy discontinuation and outcome in patients with advanced renal cell carcinoma treated with immune-based combinations (ARON-1 study).

Javier Molina-Cerrillo, Giandomenico Roviello, Maria T Bourlon

Pageof 13

Frequent Collaborators

19 joint publications

Melissa Bersanelli

14 joint publications

Sara Elena Rebuzzi

13 joint publications

Giuseppe Luigi Banna

10 joint publications

Ugo De Giorgi

10 joint publications

Giuseppe Fornarini

9 joint publications

Pasquale Rescigno

8 joint publications

Alessio Cortellini

8 joint publications

Alessio Signori

8 joint publications

Michele Maffezzoli

7 joint publications

Francesco Massari

Frequent Collaborators

19 joint publications

Melissa Bersanelli

14 joint publications

Sara Elena Rebuzzi

13 joint publications

Giuseppe Luigi Banna

10 joint publications

Ugo De Giorgi